Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lebrón JA[au]:

P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin. Ostos FJ et al. Chem Asian J. (2017)

Influence of the degree of oligomerization of surfactants on the DNA/surfactant interaction. López A et al. Colloids Surf B Biointerfaces. (2019)

Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation. López-López M et al. J Colloid Interface Sci. (2018)

Search results

Items: 25

1.

Influence of the degree of oligomerization of surfactants on the DNA/surfactant interaction.

López A, López-Cornejo P, López-López M, Lebrón JA, Ostos FJ, Pérez-Alfonso D, Oviedo J, Laschewsky A, Moyá ML.

Colloids Surf B Biointerfaces. 2019 Oct 1;182:110399. doi: 10.1016/j.colsurfb.2019.110399. Epub 2019 Jul 27.

PMID:
31377609
2.

Analysis of exposure margins in developmental toxicity studies for detection of human teratogens.

Andrews PA, Blanset D, Costa PL, Green M, Green ML, Jacobs A, Kadaba R, Lebron JA, Mattson B, McNerney ME, Minck D, Oliveira LC, Theunissen PT, DeGeorge JJ.

Regul Toxicol Pharmacol. 2019 Jul;105:62-68. doi: 10.1016/j.yrtph.2019.04.005. Epub 2019 Apr 11.

PMID:
30981719
3.

Use of a Bile Salt Export Pump Knockdown Rat Susceptibility Model to Interrogate Mechanism of Drug-Induced Liver Toxicity.

Li Y, Evers R, Hafey MJ, Cheon K, Duong H, Lynch D, LaFranco-Scheuch L, Pacchione S, Tamburino AM, Tanis KQ, Geddes K, Holder D, Zhang NR, Kang W, Gonzalez RJ, Galijatovic-Idrizbegovic A, Pearson KM, Lebron JA, Glaab WE, Sistare FD.

Toxicol Sci. 2019 Jul 1;170(1):180-198. doi: 10.1093/toxsci/kfz079.

PMID:
30903168
4.

Preparation and Characterization of New Liposomes. Bactericidal Activity of Cefepime Encapsulated into Cationic Liposomes.

Moyá ML, López-López M, Lebrón JA, Ostos FJ, Pérez D, Camacho V, Beck I, Merino-Bohórquez V, Camean M, Madinabeitia N, López-Cornejo P.

Pharmaceutics. 2019 Feb 6;11(2). pii: E69. doi: 10.3390/pharmaceutics11020069.

5.

Preparation and characterization of metallomicelles of Ru(II). Cytotoxic activity and use as vector.

Lebrón JA, Ostos FJ, López-López M, Moyá ML, Kardell O, Sánchez A, Carrasco CJ, García-Calderón M, García-Calderón CB, Rosado IV, López-Cornejo P.

Colloids Surf B Biointerfaces. 2019 Mar 1;175:116-125. doi: 10.1016/j.colsurfb.2018.11.081. Epub 2018 Nov 29.

PMID:
30529817
6.

Colloidal nanoelectronic state machines based on 2D materials for aerosolizable electronics.

Koman VB, Liu P, Kozawa D, Liu AT, Cottrill AL, Son Y, Lebron JA, Strano MS.

Nat Nanotechnol. 2018 Sep;13(9):819-827. doi: 10.1038/s41565-018-0194-z. Epub 2018 Jul 23.

PMID:
30038369
7.

Importance of hydrophobic interactions in the single-chained cationic surfactant-DNA complexation.

López-López M, López-Cornejo P, Martín VI, Ostos FJ, Checa-Rodríguez C, Prados-Carvajal R, Lebrón JA, Huertas P, Moyá ML.

J Colloid Interface Sci. 2018 Jul 1;521:197-205. doi: 10.1016/j.jcis.2018.03.048. Epub 2018 Mar 15.

PMID:
29571101
8.

P-Sulfocalix[6]arene as Nanocarrier for Controlled Delivery of Doxorubicin.

Ostos FJ, Lebrón JA, Moyá ML, López-López M, Sánchez A, Clavero A, García-Calderón CB, Rosado IV, López-Cornejo P.

Chem Asian J. 2017 Mar 16;12(6):679-689. doi: 10.1002/asia.201601713. Epub 2017 Feb 28.

PMID:
28112869
9.

Cooperative interaction between metallosurfactants, derived from the [Ru(2,2'-bpy)3](2+) complex, and DNA.

Lebrón JA, Ostos FJ, Moyá ML, López-López M, Carrasco CJ, López-Cornejo P.

Colloids Surf B Biointerfaces. 2015 Nov 1;135:817-24. doi: 10.1016/j.colsurfb.2015.08.052. Epub 2015 Aug 30.

PMID:
26344065
10.

Binding of DNA by a dinitro-diester calix[4]arene: denaturation and condensation of DNA.

Ostos FJ, Lebron JA, Moyá ML, Deasy M, López-Cornejo P.

Colloids Surf B Biointerfaces. 2015 Mar 1;127:65-72. doi: 10.1016/j.colsurfb.2015.01.019. Epub 2015 Jan 20.

PMID:
25645752
11.

Reliable quantification of mRNA in archived formalin-fixed tissue with or without paraffin embedding.

Wang Z, Lebron JA, Wolf JJ.

J Pharmacol Toxicol Methods. 2015 Jan-Feb;71:103-9. doi: 10.1016/j.vascn.2014.09.007. Epub 2014 Sep 30.

PMID:
25280797
12.

Interaction between monomers of two surfactants derived from the [Ru(2,2'-bpy)(3)](2+) complex and α, β and γ-cyclodextrins: formation of [2]- and [3]-pseudorotaxanes.

Lopez-Lopez M, Montilla F, Olivares M, Lebron JA, Moya ML, Lopez-Cornejo P.

Dalton Trans. 2013 May 7;42(17):6171-81. doi: 10.1039/c3dt32197e. Epub 2013 Mar 25.

PMID:
23525374
13.

A multi-species assay for siRNA-mediated mRNA knockdown analysis without the need for RNA purification.

Wang Z, Pacchione SJ, Niu Z, Troilo PJ, Griffiths TG, Striano KL, Lebron JA, Wolf JJ.

J Pharmacol Toxicol Methods. 2011 Mar-Apr;63(2):174-9. doi: 10.1016/j.vascn.2010.09.006. Epub 2010 Sep 25.

PMID:
20884365
14.

Binding and uptake of H-ferritin are mediated by human transferrin receptor-1.

Li L, Fang CJ, Ryan JC, Niemi EC, Lebrón JA, Björkman PJ, Arase H, Torti FM, Torti SV, Nakamura MC, Seaman WE.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3505-10. doi: 10.1073/pnas.0913192107. Epub 2010 Feb 4.

15.

Nonclinical safety assessment of vaccines and adjuvants.

Wolf JJ, Kaplanski CV, Lebron JA.

Methods Mol Biol. 2010;626:29-40. doi: 10.1007/978-1-60761-585-9_3. Review.

PMID:
20099119
16.

Adaptation of the WHO guideline for residual DNA in parenteral vaccines produced on continuous cell lines to a limit for oral vaccines.

Lebron JA, Troilol PJ, Pacchione S, Griffiths TG, Harper LB, Mixson LA, Jackson BE, Michna L, Barnum AB, Denisova L, Johnson CN, Maurer KL, Morgan-Hoffman S, Niu Z, Roden DF, Wang Z, Wolf JJ, Hamilton TR, Laux KM, Soper KA, Ledwith BJ.

Dev Biol (Basel). 2006;123:35-44; discussion 55-73.

PMID:
16566435
17.

Ensuring the quality, potency and safety of vaccines during preclinical development.

Lebron JA, Wolf JJ, Kaplanski CV, Ledwith BJ.

Expert Rev Vaccines. 2005 Dec;4(6):855-66. Review.

PMID:
16372881
18.

Binding to the transferrin receptor is required for endocytosis of HFE and regulation of iron homeostasis.

Ramalingam TS, West AP Jr, Lebrón JA, Nangiana JS, Hogan TH, Enns CA, Bjorkman PJ.

Nat Cell Biol. 2000 Dec;2(12):953-7. Retraction in: Nat Cell Biol. 2003 Jul;5(7):680.

PMID:
11146662
19.

Crystal structure of the hereditary haemochromatosis protein HFE complexed with transferrin receptor.

Bennett MJ, Lebrón JA, Bjorkman PJ.

Nature. 2000 Jan 6;403(6765):46-53.

PMID:
10638746
20.

The hemochromatosis protein HFE competes with transferrin for binding to the transferrin receptor.

Lebrón JA, West AP Jr, Bjorkman PJ.

J Mol Biol. 1999 Nov 19;294(1):239-45.

PMID:
10556042
21.
22.

Tolerization of adult mice to immunodominant proteins before monoclonal antibody production.

Lebrón JA, Shen H, Bjorkman PJ, Ou S.

J Immunol Methods. 1999 Jan 1;222(1-2):59-63.

PMID:
10022372
23.

Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor.

Lebrón JA, Bennett MJ, Vaughn DE, Chirino AJ, Snow PM, Mintier GA, Feder JN, Bjorkman PJ.

Cell. 1998 Apr 3;93(1):111-23.

24.

The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding.

Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, Tsuchihashi Z, Sigal E, Bjorkman PJ, Schatzman RC.

Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1472-7.

25.

Extended repertoire of permissible peptide ligands for HLA-B*2702.

Raghavan M, Lebrón JA, Johnson JL, Bjorkman PJ.

Protein Sci. 1996 Oct;5(10):2080-8.

Supplemental Content

Loading ...
Support Center